Veterinary Drug Eprinomectin

Name: Veterinary Drug Eprinomectin
Availability: veterinary-drug-eprinomectin-207697.html

Category:Intermediates > Pharmaceutical Intermediates
Product Name:Veterinary Drug Eprinomectin
CAS No.: 123997-26-2
Standard:In-house Standards
Price(USD):650.00
Company:Xi’an Lyphar Biotech Co., LTD

Send Inquiry

Favorites

Similar Products

Propantheline Bromide

carbomer 974P

Coenzyme Q10

Refined Fish Oil

Black Currant Extract

Hydrocortisone

Basic Info

Grade: Pharmaceutical Grade

Factory Location: Shaanxi

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia
Monthly Production Capacity: 800 Kilogram/Kilograms

Packaging Information: 25kgs packaging Fiber drum outside and plastic bag inside 1-25kgs packaging aluminium bag outside and double plastic bag inside
Delivery Lead Time: up to order

Sample Provided: no

Payment Terms: L/C, T/T,

Veterinary Drug Eprinomectin

Product Name-----Eprinomectin------Batch No.---------------LY20170320

Quantity--------------56.5 Kg--------------Production date------2017/03/20

Expiry Date---------2019/03/09---------Test standard----------USP35

Items	Specifications	Results
Appearance	White to yellowish crystalline powder	Qualified
Identification	Infrared Absorption	Qualified
	The retention times of the Component B1a peak and the Component B1b peak in the chromatogram of the Assay preparation correspond to those in the chromatogram of the standard preparation	Qualified
Specific rotation	+132 °~ +140 °	+137 °
Water	≤2.0%	0.3%
Residue on ignition	≤0.1%	0.1%
Heavy metals	≤10ppm	10ppm
Residual solvents	Acetonitrile ≤0.005%	0.003%
	Sum of all solvent ≤0.5%	0.2%
8a-oxo-B1a	≤0.5%	0.1%
Related compounds	Related compounds with relative retentions of 0.23,0.93, and 1.16 correspond to B1a peak≤ 1.0%	0.5%
Related compounds	Impurity A ≤1.0%	0.2%
	Impurity E ≤ 1.0%	0.1%
	All other known impurities ≤0.5%	0.2%
	Total unknown impurities≤ 1.0%	0.3%
	Total impurities ≤5.0%	1.3%
Assay	Component B1a ≥90.0%	93.1%
	Component B1a and Component B1b≥ 95.0%	98.7%
Conclusion	The results conform with USP35

Eprinomectin is moderately used in ruminants, mainly in pour-ons and injectables. So far it is not used in swine, poultry or horses. Use in cats as a spot-on (in combination with other actives) is still rather scarce. So far it is not used in dogs.

In most finished products, efficacy and safety depend not only on the amount of active ingredient(s) but also on their formulations (i.e. the type and amount of so-called inert ingredients), particularly in injectables and in topical pour-ons and spot-ons. These inert ingredients can significantly affect the pharmacokinetic behavior (e.g. absorption through the skin or from the injection site, distribution within the body, spreading throughout the body surface, etc.). Generic products usually contain the same amount of active ingredient(s) as the original product, but often in quite different formulations. In many cases, the curative (therapeutic) efficacy of the different formulations is quite comparable, but the protective (prophylactic) efficacy that determines the length of protection against re-infestations may be rather different.

Send your message to this supplier

From:
Message:
Upload Images / Files
- Supports jpg, jpeg, png,
gif, pdf, doc, docx,
xls, xlsx, txt, rar and zip
- Max upload 3 files;
Max total size: 3MB
(0/3)

Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now
Verification:

Veterinary Drug Eprinomectin

You may like